5-HT1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleus

European Neuropsychopharmacology

Volumn 18, Issue 4, 2008, Pages 286-294

  Dos Santos, Lucinéia ^a   de Andrade, Telma G C S ^b   Zangrossi Jr , Hélio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

5 HT1A receptors; Dorsal hippocampus; Generalized anxiety and panic; Median raphe nucleus; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; KAINIC ACID; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR; AMINO ACID RECEPTOR STIMULATING AGENT; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR; BRAIN REGION; CONTROLLED STUDY; ESCAPE BEHAVIOR; GENERALIZED ANXIETY DISORDER; HIPPOCAMPUS; INHIBITION (PSYCHOLOGY); LOCOMOTION; MALE; MAZE TEST; MEDIAN RAPHE NUCLEUS; MESENCEPHALON; MICROINJECTION; NERVE CELL STIMULATION; NONHUMAN; PANIC; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL; TASK PERFORMANCE; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; CYTOLOGY; DRUG EFFECT; ELECTROSTIMULATION; METABOLISM; MOTOR ACTIVITY; NERVE CELL; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RAPHE NUCLEUS; WISTAR RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; ELECTRIC STIMULATION; EXCITATORY AMINO ACID AGONISTS; HIPPOCAMPUS; KAINIC ACID; MALE; MICROINJECTIONS; MOTOR ACTIVITY; NEURONS; PIPERAZINES; PYRIDINES; RAPHE NUCLEI; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 38949092027     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2007.07.007     Document Type: Article

References (63)

1. Adell A., and Artigas F. A microdialysis study of the in vivo release of 5-HT in the median raphe nucleus of the rat. Br. J. Pharmacol. 125 6 (1998) 1361-1367
2. Aghajanian G.K. Chemical-feedback regulation of serotonin-containing neurons in brain. Ann. N. Y. Acad. Sci. 193 (1972) 86-94
3. Andrade R. Whole-cell and perforated-patch recording of serotonin responses in the rat hippocampus. J. Chem. Neuroanat. 5 (1992) 339-341
4. Andrade T.G.C.S., Macedo C.E.A., Zangrossi Jr. H., and Graeff F.G. Anxiolytic-like effects of median raphe nucleus lesion in the elevated T-maze. Behav. Brain Res. 153 (2004) 55-60
5. 1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur. J. Pharmacol. 264 3 (1994) 259-264
6. Azmitia E.C., and Segal M. An autoradiographic analysis of differential ascending projections of the dorsal and median raphe. J. Comp. Neurol. 179 3 (1978) 641-667
7. Beck S.G., Pan Y., Akanwa A.C., and Kirby L.G. Median and dorsal raphe neurons are not electrophysiologically identical. J. Neurophysiol. 91 2 (2004) 994-1005
8. Beijamini V., and Andreatini R. Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze. Pharmacol. Res. 48 2 (2003) 199-207
9. 1A receptor agonist 8-OH-DPAT. Brain Res. 640 1-2 (1994) 223-228
10. 1A in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modified Geller-Seifter conflict model. Neuropharmacology 39 6 (2000) 1037-1043
11. Cheeta S., Kenny P.J., and File S.E. Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal tests of anxiety. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 24 7 (2000) 1053-1067
12. Dos Santos L., Andrade T.G.C.S., and Zangrossi Jr. H. Serotonergic neurons in the median raphe nucleus regulate inhibitory avoidance but not escape behavior in the rat elevated T-maze test of anxiety. Psychopharmacology (Berl.) 179 (2005) 733-741
13. Dudley T.E., Dinardo L.A., and Glass J.D. In vivo assessment of the midbrain raphe nuclear regulation serotonin release in the hamster suprachiasmatic nucleus. J. Neurophysiol. 81 4 (1999) 1469-1477
14. File S.E., and Zangrossi Jr. H. "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?. Psychopharmacology (Berl.) 110 1-2 (1993) 240-244
15. File S.E., Zangrossi Jr. H., Viana M., and Graeff F.G. Trial 2 in the elevated plus-maze: a different form of fear?. Psychopharmacology (Berl.) 111 4 (1993) 491-494
16. 1A receptor modulation of anxiety in two ethological animal tests. J. Neurosci. 16 15 (1996) 4810-4815
17. File S.E., Gonzales L.E., and Gallant R. Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on trial 2 in the elevated plus-maze test of anxiety. Neuropsychopharmacology 21 2 (1999) 312-320
18. File S.E., Kenny P.J., and Cheeta S. The paper of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol. Biochem. Behav. 66 1 (2000) 65-72
19. Fletcher P.J., Korth K.M., and Chambers J.W. Selective destruction of brain serotonin neurons by 5,7-dihydroxytryptamine increases responding for a conditioned reward. Psychopharmacology (Berl.) 147 3 (1999) 291-299
20. Fletcher P.J., Korth K.M., and Chambers J.W. Depletion of brain serotonin following intra-raphe injections of 5,7-dihydroxytryptamine does not alter d-amphetamine self-administration across different schedule and access conditions. Psychopharmacology (Berl.) 146 2 (1999) 185-193
21. Fornal C.A., Metzler C.W., Gallegos R.A., Veasey S.C., McCreary A.C., and Jacobs B.L. WAY 100635 a potent and selective 5-hydroxytryptamine 1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135. J. Pharmacol. Exp. Ther. 278 2 (1996) 752-762
22. 1A receptor function: a link between anxiety and depression?. Pharmacol. Biochem. Behav. 59 4 (1998) 787-792
23. Graeff F.G., and Zangrossi Jr. H. Animal models of anxiety. In: D'Haenen H., den Boer J.A., and Willner P. (Eds). Biological Psychiatric (2002), Wiley, Chichester 879-893
24. Graeff F.G., Viana M.B., and Tomaz C. The elevated T maze, a new experimental model of anxiety and memory: effect of diazepam. Braz. J. Med. Biol. Res. 26 1 (1993) 67-70
25. Graeff F.G., Netto C.F., and Zangrossi Jr. H. The elevated T-maze, as an experimental model of anxiety. Neurosci. Biobehav. Rev. 23 2 (1998) 237-246
26. Gray J.A., and McNaughton N. The Neuropsychology of Anxiety. 2nd edn (2000), Oxford University Press, Oxford
27. Haddjeri N., Lavoie N., and Blier P. Electrophysiological evidence for the tonic activation of 5-HT(1A) autoreceptors in the rat dorsal raphe nucleus. Neuropsychopharmacology 29 10 (2004) 1800-1806
28. Hajos M., Hoffmann W.E., Tetko I.V., Hyland B., Sharp T., and Villa A.E. Different tonic regulation of neuronal activity in the rat dorsal raphe and medial prefrontal cortex via 5-HT(1A) receptors. Neurosci. Lett. 304 3 (2001) 129-132
29. 1A receptor-mediated autoinhibition does not function at physiological firing rates: evidence from in vitro electrophysiological studies in the rat dorsal raphe nucleus. Neuropharmacology 43 6 (2002) 959-965
30. 1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?. J. Pharmacol. Exp. Ther. 272 2 (1995) 920-929
31. Kalsner S. The question of feedback at the somadendritic region and antidepressant drug action. Brain Res. Bull. 52 6 (2000) 467-473
32. Kasamo K., Suzuki T., Tada K., Ueda N., Matsuda E., Ishikawa K., and Kojima T. Endogenous 5-HT tonically inhibits spontaneous firing activity of dorsal hippocampus CA1 pyramidal neurons through stimulation of 5-HT(1A) receptors in quiet awake rats: in vivo electrophysiological evidence. Neuropsychopharmacology 24 2 (2001) 141-151
33. 1A and not by muscarinic M1 receptors. Neuropharmacology 39 2 (2000) 300-307
34. 1A autoreceptors of the dorsal and median raphe nuclei. J. Pharmacol. Exp. Ther. 269 3 (1994) 1268-1279
35. Liu R.J., Lambe E.K., and Aghajanian G.K. Somatodendritic autoreceptor regulation of serotonergic neurons: dependence on l-tryptophan and tryptophan hydroxylase-activating kinases. Eur. J. Neurosci. 21 4 (2005) 945-958
36. Marcinkiewicz M., Verge D., Gozlan H., Pichat L., and Hamon M. Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain. Brain Res. 291 1 (1984) 159-163
37. 1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurons firing. Br. J. Pharmacol. 117 4 (1996) 750-756
38. Nunes-De-Souza R.L., Canto-De-Souza A., and Rodgers R.J. Effects of intra-hippocampal infusion of WAY-100635 on plus-maze behavior in mice. Influence of site of injection and prior test experience. Brain Res. 927 1 (2002) 87-96
39. Nutt D.J. Overview of diagnosis and drug treatments of anxiety disorders (review). CNS Spectr. 10 1 (2005) 49-56
40. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, San Diego
41. Pazos A., and Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346 2 (1985) 205-230
42. Pobbe R.L., and Zangrossi Jr. H. 5-HT(1A) and 5-HT(2A) receptors in the rat dorsal periaqueductal gray mediate the antipanic-like effect induced by the stimulation of serotonergic neurons in the dorsal raphe nucleus. Psychopharmacology (Berl.) 183 3 (2005) 314-321
43. Poltronieri S.C., Zangrossi Jr. H., and de Barros Viana M. Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze. Behav. Brain Res. 147 1-2 (2003) 185-192
44. Romaniuk A., Koprowska M., Krotewicz M., Strzelczuk M., and Wieczorek M. Effects of 8-OH-DPAT administration into the dorsal raphe nucleus and dorsal hippocampus on fear behavior and regional brain monoamines distribution in rats. Behav. Brain Res. 120 1 (2001) 47-57
45. 1A receptor agonists 8-OH-DPAT, ipsapirone and buspirone in the rat. Eur. J. Pharmacol. 249 3 (1993) 341-351
46. 1A receptor agonists in the rat. J. Pharmacol. Exp. Ther. 265 2 (1993) 572-579
47. Sena L.M., Bueno C., Pobbe R.L., Andrade T.G., Zangrossi Jr. H., and Viana M.B. The dorsal raphe nucleus exerts opposed control on generalized anxiety and panic-related defensive responses in rats. Behav. Brain Res. 142 1-2 (2003) 125-133
48. Shim I., Javaid J., and Wirtshafter D. Dissociation of hippocampal serotonin release and locomotor activity following pharmacological manipulations of the median raphe nucleus. Behav. Brain Res. 89 1-2 (1997) 191-198
49. 1A receptor antagonists on turnover and release of 5-HT in guinea-pig brain in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 359 2 (1999) 110-116
50. 1A receptors in classical fear conditioning in C57BL/6J mice. J. Neurosci. 20 (2000) 8515-8527
51. 1A receptors. Hippocampus 14 2 (2004) 143-147
52. Tao R., Ma Z., and Auerbach S.B. Influence of AMPA/kainate receptors on extracellular 5-hydroxytryptamine in rat midbrain raphe and forebrain. Br. J. Pharmacol. 121 8 (1997) 1707-1715
53. Teixeira R.C., Zangrossi H., and Graeff F.G. Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacol. Biochem. Behav. 65 4 (2000) 571-576
54. Thomas D.R., and Hagan J.J. 5-HT7 receptors. Curr. Drug Targets CNS Neurol. Disord. 3 1 (2004) 81-90
55. Thomas D.R., Gittins S.A., Collin L.L., Middlemiss D.N., Riley G., Hagan J., Gloger I., Ellis C.E., Forbes I.T., and Brown A.M. Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719. Br. J. Pharmacol. 124 6 (1998) 1300-1306
56. Vertes R.P. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J. Comp. Neurol. 313 4 (1991) 643-668
57. Vertes R.P., Fortin W.J., and Crane A.M. Projections of the median raphe nucleus in the rat. J. Comp. Neurol. 407 4 (1999) 555-582
58. Viana M.B., Tomaz C., and Graeff F.G. The elevated T-maze: a new animal model of anxiety and memory. Pharmacol. Biochem. Behav. 49 3 (1994) 549-554
59. Wirtshafter D., and McWilliams C. Supression of locomotor activity produced by acute injections of the kainic acid into the median raphe nucleus. Brain Res. 408 1-2 (1987) 349-352
60. Wirtshafter D., Klitenick M.A., and Asin K.E. Evidence against serotonin involvement in the hyperactivity produced by injections of muscimol into the median raphe nucleus. Pharmacol. Biochem. Behav. 27 1 (1987) 45-52
61. Zangrossi Jr. H., and Graeff F.G. Behavioral validation of the elevated T-maze, a new animal model of anxiety. Brain Res. Bull. 44 1 (1997) 1-5
62. Zangrossi Jr. H., Viana M.B., Zanoveli J., Bueno C., Nogueira R.L., and Graeff F.G. Serotonergic regulation of inhibitory avoidance and one-way escape in the elevated T-maze. Neurosci. Biobehav. Rev. 25 7-8 (2001) 637-645
63. 1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety. Behav. Pharmacol. 16 7 (2005) 543-552